Repligen RGEN
NASDAQ RGEN
$164.68 -0.37 (-0.22%)
As of: Sep 10, 2026 · 3:59 PM EDT

Repligen (RGEN) Total Non-Current Liabilities (2011 - 2026)

Repligen's (RGEN) quarterly Total Non-Current Liabilities came in at $821.1 million in Q2 2026, up 14.53% year-over-year from $716.9 million in Q2 2025, and up 1.55% quarter-over-quarter from $808.6 million in Q1 2026.

Analysis

Repligen (RGEN) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends

Repligen (RGEN) has reported Total Non-Current Liabilities for 16 consecutive years, with $821.1 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 14.53% year-over-year to $821.1 million in Q2 2026; TTM through Jun 2026 was $821.1 million, a 14.53% increase from a year earlier, with the FY2025 full-year figure at $707.7 million, down 3.07% from the prior year.
  • Total Non-Current Liabilities was $821.1 million for Q2 2026 at Repligen, up from $808.6 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $821.1 million in Q2 2026 and troughed at $170.1 million in Q3 2023.
  • A 5-year average of $525.4 million and a median of $706.1 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities decreased 21.54% in 2023 and soared 314.93% in 2024, its largest moves.
  • Over 5 years, Total Non-Current Liabilities stood at $216.7 million in 2022, then surged by 223.67% to $701.4 million in 2023, then grew by 4.1% to $730.2 million in 2024, then fell by 3.07% to $707.7 million in 2025, then increased by 16.01% to $821.1 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $821.1 million (Q2 2026), $808.6 million (Q1 2026), and $707.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Thermo Fisher Scientific 223.99 Bn 219.93 Bn 8.34 Bn 55.95 Bn
2 Danaher 141.56 Bn 137.22 Bn 3.61 Bn 33.25 Bn
3 Agilent Technologies 40.36 Bn 38.60 Bn 1.04 Bn 6.06 Bn
4 Illumina 30.41 Bn 29.24 Bn 770.00 Mn 3.52 Bn
5 Revvity 13.50 Bn 12.48 Bn 416.87 Mn 4.05 Bn
6 Bio-Techne 11.25 Bn 10.98 Bn 211.39 Mn 457.16 Mn
7 Bio-Rad Laboratories 9.88 Bn 8.26 Bn 345.80 Mn 2.88 Bn
8 Repligen 9.29 Bn 8.28 Bn 110.04 Mn 821.06 Mn
9 10x Genomics 8.62 Bn 8.06 Bn 112.50 Mn 197.96 Mn
10 Bruker 8.16 Bn 7.94 Bn 416.00 Mn 3.06 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 821.06 Mn
Mar 31, 2026 808.55 Mn
Dec 31, 2025 707.74 Mn
Sep 30, 2025 709.49 Mn
Jun 30, 2025 716.87 Mn
Mar 31, 2025 714.66 Mn
Dec 31, 2024 730.16 Mn
Sep 30, 2024 705.59 Mn
Jun 30, 2024 706.76 Mn
Mar 31, 2024 706.55 Mn
Dec 31, 2023 701.40 Mn
Sep 30, 2023 170.05 Mn
Jun 30, 2023 211.85 Mn
Mar 31, 2023 204.67 Mn
Dec 31, 2022 216.70 Mn
Sep 30, 2022 216.73 Mn
Jun 30, 2022 216.03 Mn
Mar 31, 2022 193.09 Mn
Dec 31, 2021 233.03 Mn
Sep 30, 2021 176.69 Mn